Philip Astley-Sparke
Director at Replimune Group; Director at enGene Therapeutics. Based in Woburn, Massachusetts.
- Rank
- 4212th of 14,452
- Companies held
- 2
- Largest holding
- REPL, 99.9% of total
- Latest SEC filing
- Aug 20, 2026
What the $26.2M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Replimune Group REPL Common Stock | Directly | 1,362,414 | $19.23 | $26.2M | 99.9% | Form 4, Aug 20, 2026 |
| enGene Therapeutics ENGN Common Shares | Directly | 20,000 | $1.76 | $35K | 0.1% | Form 3, Jul 8, 2025 |
Share counts are the amounts Philip Astley-Sparke reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 4209 | Charles A. Bacon III Director, Limbach Holdings. Warrendale, PA | $26.3M |
| 4210 | Robert W. Scully Director, KKR & Co. | $26.3M |
| 4211 | Suying Liu CEO and CFO, Mountain Crest Acquisition 6. New York, NY | $26.3M |
| 4212 | Philip Astley-Sparke Director, Replimune Group. Woburn, MA | $26.2M |
| 4213 | Ken Takanashi Director, Wave Life Sciences | $26.2M |
| 4214 | Gayn Erickson President and CEO, Aehr Test Systems. Fremont, CA | $26.2M |
| 4215 | John E. Sanfilippo Director, John B. Sanfilippo & Son. Elgin, IL | $26.2M |
Other Replimune Group insiders
All REPL insiders- Robert Coffin$35.0MDirector. #3335 overall
- Colin Love$14.9MChief Operating Officer. #6462 overall
- Sushil Patel$12.7MChief Executive Officer. #6072 overall
- Pamela Esposito$5.1MChief Business Officer. #14098 overall
- Emily Luisa Hill$3.9MChief Financial Officer. #12564 overall
- Jean M. Franchi$2.5MChief Financial Officer. #10931 overall
Questions
How much stock does Philip Astley-Sparke own?
Philip Astley-Sparke holds $26,234,421 in listed stock based on SEC filings and current prices, mostly Replimune Group (REPL). That ranks 4212th on the Stock Rich List.
Is this Philip Astley-Sparke's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Philip Astley-Sparke last buy or sell stock?
The most recent open-market trade on file is a sale of 17,657 REPL shares on May 18, 2026 at $5.08.